Secretion of Major Adrenal Androgens Following ACTH Administration in Obese Women with Different Body Fat Distribution

To investigate whether obese female subjects with abdominal obesity may have adrenal androgen hypersecretion, we examined two groups of women with abdominal (n = 12) and peripheral (n = 13) obesity (defined by body mass index and waist-to-hip ratio) and a group of seven healthy normal-weight women. All subjects underwent the following protocol study that included a) baseline determination of major adrenal androgens, b) an ACTH test, performed by administering two boli of ACTH (Synacthen, 0.2 microg/Kg BW, e.v.), at 90 min intervals, with blood samples taken for cortisol and androgens, c) an oral glucose tolerance test, performed by administering glucose (75 gr), with blood samples taken for glucose and insulin determination. Each woman also underwent a control saline study. We then investigated the relationships between basal and stimulated androgen levels, body weight and fat distribution and fasting and stimulated insulin levels. Although basal cortisol levels were similar, their increase (as AUC) after the ACTH test was higher in women with abdominal obesity than in the other groups. On the contrary, there were no significant differences in basal and stimulated serum levels of dehydroepiandrosterone, androstenedione and 17-hydroxyprogesterone among the three groups. Fasting and stimulated (as AUC) insulin levels were significantly higher (p < 0.05) in women with abdominal obesity than in those with peripheral obesity and controls. No significant correlation was present between basal and stimulated androgen levels and body mass index, the waist-to-hip ratio or basal and stimulated cortisol values. Therefore, our data indicate that adrenal androgen secretion following low-dose ACTH administration in premenopausal women does not seem to be a function of body fat mass, fat distribution and insulin levels, nor does it correlate with the capacity of the adrenal glands to secrete cortisol in both basal and stimulated conditions.

[1]  J. Rood,et al.  Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women--a clinical research center study. , 1996, The Journal of clinical endocrinology and metabolism.

[2]  P. Björntorp.  The regulation of adipose tissue distribution in humans. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[3]  R. Chattat,et al.  Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress. , 1996, Metabolism: clinical and experimental.

[4]  J. Després,et al.  Reduced testosterone and adrenal C19 steroid levels in obese men. , 1995, Metabolism: clinical and experimental.

[5]  P. Björntorp,et al.  Visceral obesity: a "civilization syndrome". , 1993, Obesity research.

[6]  J. Clore,et al.  Insulin inhibits adrenal 17,20-lyase activity in man. , 1992, The Journal of clinical endocrinology and metabolism.

[7]  R. Azziz,et al.  Effect of obesity on the response to acute adrenocorticotropin stimulation in eumenorrheic women. , 1991, Fertility and sterility.

[8]  L. Sjöström,et al.  Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. , 1990, Metabolism: clinical and experimental.

[9]  G. Schneider,et al.  Androgen-estrogen metabolism in women with upper body versus lower body obesity. , 1990, The Journal of clinical endocrinology and metabolism.

[10]  Robert E. Jones,et al.  Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. , 1988, The Journal of clinical endocrinology and metabolism.

[11]  S. Komindr,et al.  Relative sensitivity and responsivity of serum cortisol and two adrenal androgens to alpha-adrenocorticotropin-(1-24) in normal and obese, nonhirsute, eumenorrheic women. , 1986, The Journal of clinical endocrinology and metabolism.

[12]  V. Fang,et al.  Physiological dosing of exogenous ACTH. , 1985, Acta endocrinologica.

[13]  R. Hoffmann,et al.  Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. , 1983, The Journal of clinical endocrinology and metabolism.